Results 141 to 150 of about 23,850 (163)

Modifying muscle metabolic dysregulation in inclusion body myositis with pioglitazone: a single-arm trial. [PDF]

Nat Commun
Adler BL, Bene MR, Zhang C, Say C, Khare P, Mecoli C, Tiniakou E, Paik JJ, Chung T, Darrah E, Lloyd T, Pagkatipunan R, McGowan M, Mears A, Vernon HJ, Christopher-Stine L, Le A, Albayda J.   +17 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pioglitazone and statins lower incidence of Parkinson disease in patients with diabetes mellitus

European Journal of Neurology, 2021
Yu-Hung Chang, Kun-Der Lin, W -J Wu
exaly  

Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease

Neurobiology of Aging, 2011
Kentaro Hirao, Haruo Hanyu, Hidekazu Kanetaka   +2 more
exaly  

Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy

Diabetes Care, 2012
Julio Rosenstock, Afshin Salsali
exaly  

Relationship between urinary sodium excretion and pioglitazone-induced edema

Journal of Diabetes Investigation, 2010
Akinobu Nakamura, Yasuo Terauchi
exaly  

Activation of Human Peroxisome Proliferator-Activated Receptor (PPAR) Subtypes by Pioglitazone

Biochemical and Biophysical Research Communications, 2000
Hiroyuki Odaka, Yu Momose, Yasuo Sugiyama   +2 more
exaly  

Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous Stroke: Results From PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04)

Stroke, 2007
Valdis Pirags, Guntram Schernthaner, Marie-Germaine Bousser   +2 more
exaly  

Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes

Diabetes, Obesity and Metabolism, 2007
S Dejager
exaly